- Report
- April 2021
- 329 Pages
From €4691EUR$5,450USD£4,070GBP
- Drug Pipelines
- March 2021
- 240 pages
From €2582EUR$3,000USD£2,240GBP
- Report
- February 2021
- 110 pages
From €4200EUR$4,880USD£3,644GBP
- Report
- January 2021
- 195 pages
From €3059EUR$3,554USD£2,654GBP
€3399EUR$3,949USD£2,949GBP
- Report
- January 2021
- 185 pages
From €3059EUR$3,554USD£2,654GBP
€3399EUR$3,949USD£2,949GBP
- Report
- January 2021
- 199 pages
From €3059EUR$3,554USD£2,654GBP
€3399EUR$3,949USD£2,949GBP
From €938EUR$1,090USD£814GBP
From €1024EUR$1,190USD£889GBP
From €938EUR$1,090USD£814GBP
- Drug Pipelines
- September 2020
- 75 pages
From €1721EUR$2,000USD£1,493GBP
- Drug Pipelines
- September 2020
- 75 pages
From €1291EUR$1,500USD£1,120GBP
- Drug Pipelines
- September 2020
- 75 pages
From €1721EUR$2,000USD£1,493GBP
- Drug Pipelines
- September 2020
- 75 pages
From €1721EUR$2,000USD£1,493GBP
- Drug Pipelines
- June 2020
- 4664 pages
From €2152EUR$2,500USD£1,867GBP
- Drug Pipelines
- June 2020
- 1397 pages
From €1721EUR$2,000USD£1,493GBP
- Report
- January 2021
- 74 pages
From €1510EUR$1,754USD£1,310GBP
€1677EUR$1,949USD£1,455GBP
- Report
- January 2021
- 89 pages
From €1510EUR$1,754USD£1,310GBP
€1677EUR$1,949USD£1,455GBP
- Report
- January 2021
- 63 pages
From €1510EUR$1,754USD£1,310GBP
€1677EUR$1,949USD£1,455GBP
From €1523EUR$1,770USD£1,322GBP
From €1523EUR$1,770USD£1,322GBP

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more